Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10159657 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) | |
US11413259 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) | |
US10420735 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) | |
US10226436 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) | |
US10568850 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) | |
US11602508 | LONG GROVE PHARMS | Norepinephrine compositions and methods therefor |
Jan, 2038
(13 years from now) |
Market Authorisation Date: 06 October, 2022
Treatment: Indicated to raise blood pressure in adult patients with severe, acute hypotension
Dosage: SOLUTION;INTRAVENOUS
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10888534 | INFORLIFE | Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags |
Apr, 2039
(15 years from now) |
Market Authorisation Date: 15 September, 2022
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS